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The citrate transporter of Leuconostoc mesenteroides
(CitP) catalyzes exchange of divalent anionic citrate
from the medium for monovalent anionic lactate, which
is an end product of citrate degradation. The exchange
generates a membrane potential and thus metabolic en-
ergy for the cell. The mechanism by which CitP trans-
ports both a divalent and a monovalent substrate was
the subject of this investigation. Previous studies indi-
cated that CitP is specific for substrates containing a
2-hydroxycarboxylate motif, HO-CR2-COO
2. CitP has a
high affinity for substrates that have a “second” carbox-
ylate at one of the R groups, such as divalent citrate and
(S)-malate (Bandell, M., and Lolkema, J. S. (1999) Bio-
chemistry 38, 10352–10360). Monovalent anionic sub-
strates that lack this second carboxylate were found to
bind with a low affinity. In the present study we have
constructed site-directed mutants, changing Arg-425
into a lysine or a cysteine residue. By using two sub-
strates, i.e. (S)-malate and 2-hydroxyisobutyrate, the
substrate specificity of the mutants was analyzed. In
both mutants the affinity for divalent (S)-malate was
strongly decreased, whereas the affinity for monovalent
2-hydroxyisobutyrate was not. The largest effect was
seen when the arginine was changed into the neutral
cysteine, which reduced the affinity for (S)-malate over
50-fold. Chemical modification of the R425C mutant
with the sulfhydryl reagent 2-aminoethyl methanethio-
sulfonate, which restores the positive charge at position
425, dramatically reactivated the mutant transporter.
The R425C and R425K mutants revealed a substrate pro-
tectable inhibition by other sulfhydryl reagents and the
lysine reagent 2,4,6-trinitrobenzene sulfonate, respec-
tively. It is concluded that Arg-425 complexes the
charged carboxylate present in divalent substrates but
that is absent in monovalent substrates, and thus plays
an important role in the generation of the membrane
potential.
In recent years a growing number of secondary transporters
have been discovered that generate rather than consume met-
abolic energy. These transporters have been termed precursor-
product exchangers since they catalyze the uptake of a sub-
strate into the cell coupled to the exit of a metabolic end
product into the medium (for a review see Ref. 1). An example
of such a transporter is the citrate transporter (CitP) found in
Leuconostoc mesenteroides (2, 3), which catalyzes the uptake of
divalent citrate into the cell coupled to the exit of monovalent
lactate, a metabolic end product of citrate degradation in lactic
acid bacteria (4). The net charge movement over the membrane
during the exchange results in a membrane potential of phys-
iological polarity. This, in combination with the consumption of
a cytoplasmic proton in the breakdown of citrate, results in a
proton motive force and thus generates metabolic energy for
the cell. Recovery from acidic stress and resistance against
lactate toxicity have recently been suggested as alternative
roles for the metabolic pathway (5).
The ability of CitP to transport two such different substrates
as citrate and lactate is associated with a high specificity for
the 2-hydroxycarboxylate motif present in both substrates (i.e.
HO-CR2-COO
2), in combination with a high promiscuity to-
ward the two R groups (6). In fact, next to the physiological
substrates, CitP is able to transport a wide range of 2-hydroxy-
carboxylates containing various R groups. The ability to accept
both a neutral as well as a negatively charged R group is the
basis for membrane potential generation by CitP. CitP is
known to have a high affinity for divalent di- and tricarboxy-
lates like citrate and (S)-malate, which have a “second” carbox-
ylate at one of the R groups (6). Monocarboxylates like lactate
and 2-hydroxyisobutyrate (2-HIB),1 which lack this second car-
boxylate, were found to bind with a low affinity but were still
transported efficiently. The high affinity of CitP for substrates
with a second carboxylate was explained by postulating a
strong, possibly electrostatic, interaction between the protein
and the second carboxylate. Positively charged residues such as
arginine, lysine, or histidine were thought to be able to partic-
ipate in such an interaction.
CitP belongs to the 2-hydroxycarboxylate transporter
(2-HCT) family (7) that contains members found in several
lactic acid bacteria as well as in Bacillus subtilis and Klebsiella
pneumoniae (8). The family contains precursor-product ex-
changers like CitP and the malate transporter MleP of Lacto-
coccus lactis, but also the Na1/citrate symporter CitS of
K. pneumoniae, suggesting that precursor-product exchangers
are “normal” secondary transporters that have been optimized
to catalyze exchange. Transporters of the 2-HCT family are
believed to consist of 11 transmembrane segments (TMSs),
based on topology studies of CitS of K. pneumoniae (9–11). The
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C terminus of the proteins resides in the periplasm. A recent
study of chimeras between the citrate transporter CitP and the
malate transporter MleP indicated that the C-terminal region
including TMS XI forms part of the substrate-binding site that
interacts with the R groups of the substrates (8). The C-termi-
nal region contains two conserved arginine residues, one of
which is located in TMS XI. The latter residue was thought to
be a good candidate for an interaction with the second carbox-
ylate of divalent substrates.
In the present study Arg-425 in TMS XI of CitP was replaced
by lysine and cysteine residues. The mutant transporters
were analyzed for their affinity toward the divalent and
monovalent substrates (S)-malate and 2-HIB, respectively.
In addition, the effect of chemical modification of residues at
position 425 and the ability of substrate to protect against
modification was investigated. It is concluded that Arg-425 is
located in the substrate-binding site where it is responsible
for a high affinity interaction with the second carboxylate of
di- and tricarboxylates.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Growth Conditions—L. lactis strain NZ9000 is
an MG1363 derivative (pepN::nisRnisK; (12)) that transports neither
citrate nor malate. The nisR and nisK genes were inserted in the
chromosome to allow induced expression of plasmid-encoded genes un-
der control of the tightly regulated nisA promoter (12). Cells harboring
the expression vector pNZcitP containing the citP gene (see below) were
grown at 30 °C in closed serum bottles and without shaking in M17
broth (Difco) supplemented with 0.5% (w/v) glucose and 5 mg/ml chlor-
amphenicol. Unless otherwise stated, expression of the transporter was
induced by growing the cells to an optical density of 0.6 measured at 660
nm (OD660), followed by addition of a 1000-fold dilution of the superna-
tant of an overnight culture of the nisin producing L. lactis strain
NZ9700 into the cultures (14). The supernatant contained approxi-
mately 10 ng of nisinA/ml (15). Growth was continued for 1 h followed
by harvesting of the cells by centrifugation. In some cases a lower level
of induction was required to allow kinetic analysis (see “Results”). Then,
cells expressing CitP were grown in the presence of a 30,000-fold dilu-
tion of the nisin containing supernatant for 0.5 h.
DNA Manipulations—General procedures for cloning and DNA ma-
nipulations were performed essentially as described by Sambrook et al.
(16). Expression vector pNZcitP codes for the CitP protein with 10
additional histidine residues at the N terminus (8). R425C and R425K
mutations were introduced in the citP gene in two steps by overlap
extension polymerase chain reaction (17). All polymerase chain reac-
tion-amplified DNA fragments were sequenced to confirm the nucleo-
tide sequence. Ligation mixtures were transformed to L. lactis NZ9000
by electroporation as described by Holo and Nes (18).
Preparation of Right-Side-Out Membrane Vesicles—Right-side-out
(RSO) membrane vesicles of NZ9000 cells expressing wild type or mu-
tant CitP were prepared by the osmotic shock lysis procedure in the
presence of 5 mM (S)-malate, essentially as described previously (6).
Membrane vesicles were washed once with 50 mM potassium phos-
phate, pH 6, containing 5 mM (S)-malate and concentrated by centrif-
ugation in an Eppendorf table top centrifuge operated at full speed for
5 min. The internal pool of (S)-malate was labeled with (S)-[14C]malate
by incubating the concentrated membranes with 186.7 mM L-[1,4(2,
3)14C]malate for 1 h in the presence of 1 mM valinomycin and 0.5 mM
nigericin. Protein concentrations were determined as described by
Lowry et al. (19). In case the vesicles were used for chemical modifica-
tion studies, (S)-malate was omitted in the preparation procedure, and
loading of the vesicles with (S)-[14C]malate was done as described under
“Chemical Modification.”
Exchange Measurements—Aliquots of 2 ml of (S)-[14C]malate-loaded
vesicles were diluted into 200 ml of 50 mM potassium phosphate, pH 6,
containing substrates at the indicated concentrations at 20 °C. Internal
radioactivity was determined at different time points by dilution with
ice-cold LiCl followed by rapid filtration, as described (6). Final mem-
brane protein concentrations in the assays were between 250 and 350
mg/ml. To evaluate the data, initial rates of exchange were determined
by fitting the data to an exponential decay using nonlinear fitting
procedures provided by the Sigma Plot software (Jandel Scientific, San
Rafael, CA), as described previously (7). The rate of efflux in the ab-
sence of external substrate was subtracted from the observed rates.
Exchange rates were determined at different external substrate con-
centrations to estimate the affinity constant Km
app. The data were fitted
to an equation describing competitive inhibition, taking into account
the effect of (S)-[14C]malate in the external buffer caused by the dilution
of the (S)-[14C]malate-loaded membrane vesicles (6).
Chemical Modification—RSO membrane vesicles (10 mg protein/ml)
prepared in the absence of (S)-malate were incubated for the indicated
times in 50 mM potassium phosphate containing 5 mM of the lysine-
specific reagent TNBS (Fluca) or 1 mM of the sulfhydryl reagents
MTSEA, MTSES, MTSET (Anatrace), pCMB, and pCMBS (Sigma) at
23 °C. Reactions with the sulfhydryl reagents were performed at pH 6
and with TNBS at a range of pH values. Following incubation, the
vesicles were diluted 15 times in 50 mM potassium phosphate, pH 6, and
concentrated by centrifugation in an Eppendorf table top centrifuge
operated at full speed for 5 min. The membranes were washed 3 times
using the same procedure. To load the vesicles with (S)-[14C]malate, the
concentrated vesicles were incubated overnight at 4 °C in the presence
of 5 mM (S)-malate, 186.7 mM L-[1,4(2,3)14C]malate, 1 mM valinomycin,
and 0.5 mM nigericin. Exchange activity was determined as described
above.
To test the effect of substrate on chemical modification, RSO mem-
branes were preincubated for 2 h with and without the substrate in the
presence of 1 mM valinomycin and 0.5 mM nigericin followed by reaction
with 0.1 mM pCMB for 0.5 min or with 30 mM TNBS for 2 h at pH 7. The
membranes were washed twice with 50 mM potassium phosphate, pH 6,
in the presence of substrate and 4 times in the absence of substrate. The
concentrated vesicles were loaded with 5 mM radiolabeled (S)-malate,
and exchange activity was determined as described above. To evaluate
the efficiency of the washing procedure for removing internal substrate,
vesicles were equilibrated with 60 mM 2-HIB, butyrate, (S)-malate,
(S)-citramalate, or succinate and were washed four times. In all cases
exchange rates were not significantly different from vesicles that were
incubated in the absence of substrate (data not shown).
SDS-Polyacrylamide Gel Electrophoresis and Immunoblot Analy-
sis—Right-side-out membrane vesicles were subjected to SDS-poly-
acrylamide gel electrophoresis using a 12% polyacrylamide gel matrix
(15 mg protein/lane). After electrophoresis, the proteins were trans-
ferred to poly(vinylidene difluoride) membranes and analyzed using
monoclonal antibodies directed against a His tag (Dianova, Hamburg,
Germany). Antibodies were visualized using the Western light chemi-
luminescence detection kit (Tropix, Bedford, MA).
Chemicals—L-[1,4(2,3)-14C]Malic acid (51 mCi/mmol) was obtained
from Amersham Pharmacia Biotech. All other compounds were ob-
tained from Fluka (Buchs, Switzerland) or Sigma.
RESULTS
Construction and Activity of the R425C and R425K Mutant
Transporters—Arg-425 is conserved in the transporters of the
2-HCT family and located in the C-terminal putative TMS XI
(Fig. 1). The involvement of Arg-425 in the interaction with the
second carboxylate present in divalent substrates was investi-
FIG. 1. Membrane topology and amino acid sequence of the
C-terminal part of CitP. The topology model is based on studies of the
Na1-dependent citrate transporter CitS of K. pneumoniae which is
homologous to CitP (11). Conserved residues in the amino acid sequence
alignment of the 2-HCT family (8) were indicated in gray.
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gated by constructing site-directed mutants of the citrate
transporter CitP of L. mesenteroides. Arg-425 was replaced
with Lys, a conservative mutation that retains the positive
charge, and with the neutral Cys residue. Mutant and wild
type transporters were N-terminally tagged with 10 histidines
and expressed in L. lactis NZ9000 cells using the inducible nisA
promoter system. The expression levels in the membrane were
analyzed by immunoblotting using antibodies directed against
the His tag. The apparent molecular mass of the proteins was
about 40 kDa, and under the same induction conditions, the
expression levels were similar for CitP and both mutants (Fig. 2).
Exchange provides a sensitive assay for the activity of CitP
(7). Mutant transporters were assayed for homologous ex-
change in right-side-out membrane vesicles, using the high
affinity substrate (S)-malate. Vesicles loaded with 5 mM radio-
labeled (S)-malate were diluted 100-fold into buffer. In the
absence of external substrate, efflux of (S)-malate from the
membranes down the concentration gradient was a slow proc-
ess for both wild type and mutant transporters (Fig. 3 (l )).
Only when measured for a prolonged period (Fig. 3C) signifi-
cant efflux could be observed. The rate of efflux seemed not
significantly different for the wild type and mutant transport-
ers. Dilution of the membranes containing the wild type trans-
porter in buffer containing 5 mM unlabeled (S)-malate resulted
in very rapid release of the label from the membranes due to
CitP-mediated exchange (Fig. 3A (f)). Exchange catalyzed by
the R425K and R425C mutant was considerably slower but
significantly faster than efflux (Fig. 3, B and C (f)). The Arg to
Cys mutation had a more drastic effect on the exchange rate
than the conservative Arg to Lys mutation.
Affinity for (S)-Malate and 2-HIB—The kinetic characteris-
tics of the mutant transporters were analyzed with 2-HIB and
(S)-malate, a mono- and a divalent substrate of CitP, respec-
tively (see Fig. 4). Under standard induction conditions, ex-
change catalyzed by wild type CitP was so fast that initial rates
of transport could not be measured (Fig. 3A). To allow the
analysis, CitP expression levels were reduced by varying the
inducer concentration in the growth medium (see “Experimen-
tal Procdures”).
FIG. 2. Expression levels of CitP, R425K, and R425C. RSO mem-
brane vesicles prepared from L. lactis NZ9000-expressing CitP (lane 1),
R425K (lane 2), and R425C (lane 3) were analyzed by Western blotting
using antibodies raised against the His tag. The position of the molec-
ular mass markers was indicated on the right.
FIG. 3. Homologous (S)-malate exchange catalyzed by CitP, R425K, and R425C. RSO membrane vesicles prepared from L. lactis
NZ9000-expressing CitP (A), R425K (B), and R425C (C) were preloaded with 5 mM (S)-[14C]malate and diluted 100-fold into buffer containing 5
mM (S)-malate (f) or no additions ( l ).
FIG. 4. CitP substrates. Chemical
structure of the substrates of CitP used in
this study. The R groups are defined as
RR and RS to discriminate between the
different positions of the R groups in
chiral compounds. Inset, the 2-hydroxy-
carboxylate motif.
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app for external (S)-malate at an internal concentration
of 5 mM (S)-malate was 90 mM for wild type CitP in fair agree-
ment with previous reports (6, 8). In heterologous exchange
using the same concentration of internal (S)-malate, the Km
app
for external 2-HIB was 5 mM (Fig. 5A and Table I). Replacing
Arg-425 by Lys, thus conserving the positive charge at position
425, reduced the affinity for (S)-malate about 10-fold (Fig. 5B
and Table I). Substitution for the neutral Cys residue had a
much more dramatic effect on affinity. No saturation was ob-
served up to a concentration of 10 mM (Fig. 5C). In contrast to
the decrease in the affinity for divalent (S)-malate, the R425K
and R425C mutants revealed an increased apparent affinity for
monovalent 2-HIB. The affinity of R425K increased 4-fold,
whereas R425C had a 20-fold higher affinity for 2-HIB com-
pared with wild type CitP. The maximal rates of exchange
decreased in the order CitP . R425K . R425C for both (S)-
malate and 2-HIB (Fig. 5 and Table I).
The results suggest that Arg-425 is specifically involved in
the high affinity toward the divalent (S)-malate. The positive
charge of the Arg seems to play an important role in the
interactions since the changes in (S)-malate affinity were much
less pronounced when Arg-425 was replaced with the positively
charged Lys residue.
Reactivation of the R425C Mutant—The methanethiosulfon-
ate (MTS) derivatives MTSEA, MTSES, and MTSET are small,
charged, water-soluble, and cysteine-specific reagents (20).
They form a mixed disulfide with the thiol of the cysteine via




1 for MTSES, MTSET, and MTSEA, respectively. Right-
side-out membrane vesicles containing the transporters were
treated with the MTS reagents, and (S)-malate exchange was
measured using non-saturating external (S)-malate concentra-
tions (21). Wild type CitP contains one Cys residue at position
361 in putative TMS X. Treatment of RSO membranes contain-
ing CitP with the MTS reagents had no effect on the exchange
activity (Table II). Apparently Cys-361 is not accessible to the
reagents or the modification does not affect activity. In con-
trast, exchange catalyzed by the R425C mutant was severely
affected indicating a specific modification of the Cys at position
425 (Table II). The most striking effect was seen upon incuba-
tion with MTSEA which restores a positive charge at position
425 (Fig. 6). The homologous exchange rate increased about
50-fold under the conditions of the experiment. In fact, the
exchange catalyzed by MTSEA-treated R425C was faster than
observed for the R425K mutant (compare Figs. 6 and 3B). In
contrast to MTSEA, the more bulky positively charged reagent
MTSET and the negatively charged MTSES reduced the (S)-
malate transport activity of the mutant to undetectable levels.
The results indicate that the introduction of a small positive
group at position 425 in the R425C mutant can largely restore
exchange activity.
Chemical Modification of R425K by TNBS—TNBS reacts
specifically with lysine residues and/or the N terminus of pro-
teins (22, 23) introducing a covalently linked trinitrophenyl
group in the protein. Increased reactivity at higher pH values
is characteristic for a specific reaction with an amino group
TABLE I
Kinetic parameters for CitP, R425K, and R425C in exchange






mM mM/s mM mM/s
CitPa 0.09 6 0.02 2.4 6 0.3 4.9 6 0.6 5.8 6 0.8
R425K 1.4 6 0.3 0.67 6 0.08 1.2 6 0.3 0.76 6 0.1
R425C .10b .0.07b 0.22 6 0.05 0.049 6 0.004
a Expression level for CitP was lower than for R425K and R425C (see
text).
b Lower limit; no significant saturation was observed.
TABLE II
Exchange (% of control) catalyzed by R425C and CitP after treatment
with sulfhydral reagents
RSO membrane vesicles containing R425C CitP were treated with 1
mM of the reagents for the indicated times. After washing away the
reagents, vesicles were preloaded with 5 mM (S)-[14C]malate and di-
luted 100-fold into buffer containing 5 mM (S)-malate. Rates were given
as the percentage of exchange by the untreated membranes.
R425C CitP
10 min 150 min 10 min 150 min
No addition 100 100 100 100
MTSEA 4800 100
MTSET 100 49 105
MTSES 98 40 110
PCMB 2 103
PCMBS 20 2 95
FIG. 5. Affinity of CitP (A), R425K (B), and R425C (C) for (S)-malate and 2-HIB. RSO membrane vesicles prepared from L. lactis
NZ9000-expressing CitP (A), R425K (B), or R425C (C) were preloaded with 5 mM (S)-[14C]malate and diluted 100-fold into buffer containing the
indicated concentrations of (S)-malate ( l ) or 2-HIB (). The curves were analyzed as described under “Experimental Procedures,” and the obtained
Km
app and Vmax values are given in Table I. Expression level for CitP was lower than for R425K and R425C (see text).
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(23). Treatment of right-side-out membrane vesicles containing
R425K with 5 mM TNBS at pH 6 did not reduce the exchange
activity of the transporter. However, the same treatment at pH
values of 7 and 8 resulted in the loss of 35 and 80% exchange
activity, respectively (Fig. 7A). Under the same reaction condi-
tions, TNBS had no effect on wild type CitP (Fig. 7B) indicating
a specific modification of the lysine at position 425 in the
R425K mutant. Apparently, modification of Lys-425 in the
R425K mutant renders an inactive transporter.
Accessibility of Position 425—The localization of the Cys
residue at position 425 in the R425C mutant with respect to the
membrane was investigated by the reactivity with membrane-
permeable and -impermeable thiol reagents. MTSET is a
strong base and MTSES a strong acid, and both are generally
regarded to be poorly membrane-permeable. On the other
hand, MTSEA is a weak base that equilibrates across the
membrane in its undissociated form (24). Chemical modifica-
tion of the R425C mutant by membrane-impermeable MTSES
and MTSET was incomplete even after long incubation times
(Table II). The incomplete inactivation was due to low inacti-
vation rates as higher reagent concentrations increased inac-
tivation (not shown). In contrast, the time course of activation
with membrane-permeable MTSEA was much shorter. The
stimulatory effect was saturated within 10 min.
pCMB and its sulfonic acid derivative pCMBS are organo-
mercurial reagents that react with high specificity with cys-
teine residues. pCMB is membrane-permeable, and pCMBS is
not. Treatment of right-side-out membrane vesicles containing
R425C with either pCMB or pCMBS eventually resulted in
complete inhibition of homologous (S)-malate exchange (Table
II). The same treatment had no effect on exchange catalyzed by
the wild type transporter, indicating that the Cys at position
425 was modified. Inactivation of the R425C mutant by pCMBS
was much slower than observed for of pCMB which fully inac-
tivated the transporter within 3 min (Table II). In fact, 0.5 min
of incubation with 0.1 mM pCMB resulted in 80% inhibition (see
below), while the same level of inhibition by pCMBS required
10 min of incubation at a 10-fold higher concentration. Taken
together these results indicate that Cys-425 reacts much faster
with membrane-permeable reagents, suggesting that the resi-
due is accessible at the cytoplasmic side of the membrane.
Substrate Protection against Chemical Modification—The
R425C mutant revealed a relatively high affinity for external
2-HIB in heterologous exchange (Km
app 5 0.22 mM; Table II) and,
therefore, this substrate was selected to see whether the pres-
ence of substrate could protect the mutant against inactivation
by pCMB. Right-side-out membrane vesicles were incubated
with 2-HIB to equilibrate the substrate over the membrane,
followed by treatment with pCMB, and subsequent removal of
the substrate and unreacted pCMB (see “Experimental Proce-
dures”). In the absence of 2-HIB, the treatment resulted in 80%
inhibition of exchange activity (Fig. 8A). 2-HIB protected
R425C against pCMB inactivation in a concentration-depend-
ent manner, but much higher concentrations were required
than anticipated. Protection of R425C by 2-HIB was incomplete
even at 60 mM which is far above the Km
app for external 2-HIB.
In the control experiment, 2-HIB was replaced by butyrate,
which is very similar to 2-HIB but lacks the hydroxyl group and
therefore is not a substrate of CitP (7). The presence of butyrate
did not affect the inactivation by pCMB (Fig. 8A), indicating
that the protection by 2-HIB is specific.
(S)-Malate and another high affinity substrate of CitP (S)-
citramalate (6) were tested for their potency to protect the
R425K mutant against inactivation by TNBS (Fig. 8B). In the
presence of 60 mM (S)-malate, the 70% inhibition observed in
the absence of substrate was reduced to 30%, whereas 60 mM
(S)-citramalate completely protected against inactivation un-
der the conditions of the experiment. Similarly as observed for
2-HIB above, much higher concentrations of the substrates
were required than would be expected based on the affinity
constants for external (S)-malate in the homologous exchange
reaction. In the control experiment, succinate which lacks the
2-hydroxy group of (S)-malate, and therefore is not a substrate
of CitP, had no effect on the inhibition by TNBS.
DISCUSSION
In this study, the mechanism by which CitP transports both
divalent and monovalent substrates, which is crucial to the
physiological function of membrane potential generation by the
transporter, was investigated. Previous substrate specificity
FIG. 6. Modification of R425C by MTSEA. RSO membrane vesi-
cles prepared from L. lactis NZ9000-expressing R425C were incubated
for 10 min in the presence (M and ) or absence ( l and f) of 1 mM
MTSEA. After washing, the membranes were preloaded with 5 mM
(S)-[14C]malate and diluted 100-fold into buffer containing 5 mM (S)-
malate ( and f) or no additions (M and l ).
FIG. 7. TNBS treatment of R425K (A) and CitP (B). RSO mem-
brane vesicles prepared from L. lactis NZ9000-expressing R425K and
CitP were incubated for 2 h with 5 mM TNBS at the indicated pH. After
washing, the vesicles were loaded with 5 mM (S)-[14C]malate and di-
luted 100-fold into buffer containing unsaturating (S)-malate concen-
trations, i.e. 1.5 mM (S)-malate in the case of R425C and 0.15 mM in the
case of CitP. Exchange rates were given as a percentage of the exchange
rate in the untreated membranes. Error bars represent the S.D.
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studies showed that CitP is specific for substrates containing a
2-hydroxycarboxylate motif, HO-CR2-COO
2, in which the R
groups can vary. These R groups were defined as RR and RS to
discriminate between different positions of the R groups
around the asymmetric C-2 atom in chiral substrates (Fig. 4,
inset). CitP is known to have a high affinity for substrates that
have a second charged carboxylate at the RS position, like
citrate and (S)-malate (6). Monovalent substrates that lack this
second carboxylate, like lactate and 2-HIB, were found to bind
with low affinity but were still transported efficiently. A non-
essential interaction between the protein and the second car-
boxylate of the divalent substrates was postulated that would
increase affinity for these substrates. Arg-425 was selected to
be a good candidate for the site on the protein involved in this
interaction because of the following. (i) Arg-425 is located in the
stretch of 46 residues at the C terminus, which has been sug-
gested to be involved in the interaction with the R groups (8).
(ii) Arg-425 is located in a transmembrane segment of the
transporter. (iii) Arg-425 is conserved in the 2-HCT family (8).
It is concluded that Arg-425 indeed interacts with the second
carboxylate of the divalent substrates, based on the following
observations. First, mutation of Arg-425 decreased the affinity
for divalent (S)-malate but not for monovalent 2-HIB. Second,
Arg-425 is not essential for transporter activity. Third, a posi-
tive charge at position 425 resulted in improved transport
activity. Fourth, chemical modification of the residue at posi-
tion 425 significantly affected transporter activity. Finally, the
presence of substrate protected the residue at position 425
against chemical modification. The combination of the results
strongly suggests that Arg-425 is in the substrate-binding
pocket where it interacts with the second carboxylate. The
involvement of TMS XI in the binding site is in line with the
behavior of chimeric transporters (8).
The affinities of the mutant and wild type transporters were
determined by homologous and heterologous exchange using
membrane vesicles loaded with a fixed (S)-malate concentra-
tion and varying the external substrate concentrations. The
determined affinities are for the external substrate. In a ping-
pong type exchange mechanism, the apparent affinity for the
external substrate is dependent on the affinity and concentra-
tion of the internal substrate. Non-saturating conditions at the
inside result in higher apparent affinities for the external sub-
strate and lower maximal rates. Consequently, a mutation that
lowers the affinity for internal (S)-malate decreases the Km
app
for external substrate and the maximal rate of exchange. The
kinetics observed with 2-HIB of the R425K and R425C mutants
are consistent with a decrease in internal (S)-malate affinity in
the order Arg-425, Lys-425, Cys-425, if the binding affinity for
2-HIB would not change significantly. The kinetic affinity for
external 2-HIB increases, and the maximal rate for heterolo-
gous 2-HIB/(S)-malate, as well as for homologous (S)-malate
exchange, decreases (Fig. 5). The observed decreased affinity of
the mutants for external (S)-malate in homologous exchange
strongly argues in favor of a decreased binding affinity of the
protein for (S)-malate with a subsequent lowering of the kinetic
affinity for internal (S)-malate.
The guanidinium group of the Arg-425 residue is not abso-
lutely essential for transport function since even a non-conser-
vative substitution for Cys does not abolish the activity of CitP.
However, the affinity for divalent (S)-malate was severely af-
fected by this mutation. The drop in affinity was less when
Arg-425 was mutated to Lys, and, especially, the reactivation of
R425C by MTSEA, which restores a positive charge at position
425, strongly suggests that the positive charge is essential for
high affinity binding of divalent substrates. Nevertheless, the
positive charge is not the only relevant factor since Arg-425
cannot be replaced with lysine or MTSEA-labeled cysteine
without some loss of affinity. The chemistry of the guanidinium
group allows for the formation of two hydrogen bonds, which is
known to result in an interaction of unusual strength with a
carboxylate group (25). Alternatively, only an Arg residue can
position its charge accurately relative to the substrate for an
optimal interaction. In contrast to the stimulation of exchange
by MTSEA, positively charged MTSET inhibited the R425C
mutant. The three methyl groups of the quaternary ammonium
group of the reagent are likely to interfere sterically with
substrate binding and thus inactivate the transporter. MTSES,
pCMB, and pCMBS inactivated R425C and TNBS R425K most
likely because of the presence of a negative charge on the side
chains that is expected to repel the carboxylate of the substrate
and/or by steric interference with the substrate.
In the topology model of CitP, Arg-425 is located at the
cytoplasmic side of TMS XI (9–11). The present data support
this localization. The chemical inactivation of the R425C mu-
tant in right-side-out vesicles was much faster for the mem-
brane-permeable pCMB than for its impermeable counterpart
pCMBS (Table II). Since the two probes have similar chemical
reactivities, the difference in inactivation rate suggests that
the reactive cysteine is only accessible from the inside. Simi-
larly, chemical modification by the membrane-impermeable
MTSET and MTSES was very slow, and modification by the
permeable MTSEA was fast. These low reaction rates are not
due to differences in chemical reactivity with the thiol groups.
In fact, MTSET is known to have 2.5-fold higher intrinsic
reactivity for sulfhydryls than MTSEA (13). Thus, these results
also suggest that the reaction takes place at the internal face of
the membrane. The low rate of modification with pCMBS,
MTSES, and MTSET may be explained by a slow permeation
through the membrane by these reagents followed by reaction
FIG. 8. Substrate protection against modification by pCMB (A)
and TNBS (B). A, RSO membrane vesicles containing R425C were
incubated for 0.5 min with 0.1 mM pCMB in the presence or absence of
the indicated concentrations of 2-HIB or butyrate. After washing, the
membranes were preloaded with 5 mM (S)-[14C]malate and diluted
100-fold into buffer containing 5 mM (S)-malate. B, RSO membrane
vesicles containing R425K were incubated for 2 h with 30 mM TNBS at
pH 7 in the presence or absence of 60 mM (S)-malate, (S)-citramalate, or
succinate. After washing, the vesicles were preloaded with 5 mM (S)-
[14C]malate and diluted 100-fold into buffer containing 1.5 mM (S)-
malate. Exchange rates were given as a percentage of the exchange rate
without addition of TNBS. Error bars represent the S.D.
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at the cytoplasmic side or by a low accessibility of the Cys
residue from the outside. Accessibility of a binding site residue
from either side of the membrane is not unlikely since the
transporter has to expose the binding site alternately to the
two sides of the membrane during turnover.
The presence of substrate protected against chemical modi-
fication of the residue at position 425, which is consistent with
the assignment of Arg-425 as a binding site residue. Interest-
ingly, 2-HIB protected R425C against pCMB inactivation in a
concentration-dependent manner, but protection was still in-
complete at a concentration of 60 mM, indicating a very low
affinity for the substrate. This contrasted with the high appar-
ent affinity for external 2-HIB in the exchange assays, Km
app 5
0.22 mM (Table I). The same situation was observed for the
protection of R425K by (S)-malate against inhibition by TNBS.
Possible explanations for the apparent discrepancy may be the
underestimation of the binding affinity for external substrate
when deduced from a kinetic experiment as discussed above or,
alternatively, the transporter has a much lower affinity for
internal substrate than for external substrate. In any case, full
protection against chemical modification was shown to be pos-
sible by the high affinity substrate (S)-citramalate.
In conclusion, the combination of the kinetic characteristics
of the mutants and the chemical modification and substrate
protection against chemical modification strongly suggest a
direct interaction between Arg-425 and the carboxylate at the
RS groups of the divalent substrates. The positive charge of
Arg-425 seems to be important in this interaction, but the chem-
istry of the guanidinium groups may play a role as well. Although
Arg-425 is not essential for transport by CitP, its role in specifi-
cally interacting with the second carboxylate of di- and tricar-
boxylate substrates makes it essential for the generation of the
membrane potential which is the physiological function of CitP.
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